(18629356), D. T. H., (832356), T. G., (18629359), J. F. M., (18629362), B. J. S., (18629365), J. S., (18629368), A. M. K. T., . . . (18629386), I. G. (2018). The AMPK agonist 5‐aminoimidazole‐4‐carboxamide ribonucleotide (AICAR), but not metformin, prevents inflammation‐associated cachectic muscle wasting.
Chicago Style (17th ed.) Citation(18629356), Derek T Hall, et al. The AMPK Agonist 5‐aminoimidazole‐4‐carboxamide Ribonucleotide (AICAR), but Not Metformin, Prevents Inflammation‐associated Cachectic Muscle Wasting. 2018.
MLA (9th ed.) Citation(18629356), Derek T Hall, et al. The AMPK Agonist 5‐aminoimidazole‐4‐carboxamide Ribonucleotide (AICAR), but Not Metformin, Prevents Inflammation‐associated Cachectic Muscle Wasting. 2018.
Warning: These citations may not always be 100% accurate.